Without effective treatment, pulmonary arterial hypertension results in high morbidity and mortality. This review discusses the pathogenesis of the disorder, the thorough clinical evaluation requir ...

Panelists discuss how the pathophysiology of pulmonary arterial hypertension involves complex mechanisms across multiple genetic and treatment pathways, with over 20 identified genes and four ...

Patients with acute pulmonary edema often have marked hypertension but, after reduction of the blood pressure, have a normal left ventricular ejection fraction (≥0.50). However, the pulmonary ...

Read a review that discusses the pathogenesis and classification, clinical manifestations, diagnostic assessment, prognosis, and therapeutic strategies associated with pulmonary hypertension.

Investigators provide recent information on the classification, pathophysiology, diagnosis, and treatment of pulmonary arterial hypertension, focusing specifically on its impact on women.

Pulmonary arterial hypertension (PAH) is a disease characterized by increased pulmonary vascular resistance. 1,2 Symptoms at presentation include shortness of breath, fatigue, chest pain, or ...

Pulmonary Circulation, Vol. 5, No. 3 (September 2015), pp. 590-597 (8 pages) AbstractPulmonary hypertension (PH) is an infrequently reported complication of multiple myeloma (MM). PH has been more ...

Pulmonary arterial hypertension (PAH) is a rare and severe lung disease with a life-threatening prognosis. After several positive trials, a recent study has confirmed the efficacy of a biotherapy ...

Charles Burger, MD: Pulmonary hypertension really refers to a state where the right heart is generating high pressures to circulate the blood through the lung. Pulmonary arterial hypertension is a ...

The pulmonary vasculature is the exclusive target of disease in PPH, although its pathogenesis remains speculative. The most widely accepted mechanism suggests that PPH is a disease of predisposed ...